Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

January 31, 2006

Conditions
Hemoglobinuria, Paroxysmal
Interventions
DRUG

eculizumab

Trial Locations (43)

8

St. James Hospital, Haematology Department, Dublin

1200

Ucl St. Luc, Hematology Department, Brussels

3050

Royal Melbourne Hospital, Dept. of Clinical Haematology & Medical Oncology, Parkville

4031

Universitatsklinik Basel, Division of Hematology, Basel

4102

Princess Alexandra Hospital, Oncology Haematology Radiation Department, Woolloongabba

5011

Queen Elizabeth Hospital, Dept. of Haematology, Woodville South

6000

The Royal Perth Hosptial, Department of Haematology/Level 2, Perth

6525

UMC St. Radboud, Dept. of Hematology, Nijmegen

10016

NYU Clinical Cancer Center, New York

10021

Memorial Sloan Kettering Cancer Center, New York

19104

Presbyterian Medical Center, PENN Comprehensive Hemophilia & Thrombosis Program, Philadelphia

20892

National Heart, Blood, and Lung Institute, National Institutes of Health, Bethesda

21205

Johns Hopkins University Medical Center, Baltimore

27710

Duke University Health System, Division of Cell Therapy, Heme Malignancies Program, Durham

33331

Cleveland Clinic, Dept. of Clinical Research, Weston

44195

Cleveland Clinic Foundation, Cleveland

46202

Indiana University Cancer Pavilion, Div. of Hematology-Oncology, Hematological Malignancy Program/Immunology, Indianapolis

50139

Azienda Ospedaliera Universitaria Careggi, Dipartimento di area critica medico-chirurgica, Florence

90024

University of California at Los Angeles, Los Angeles

90185

Umea University Hospital, Dept. of Internal Medicine 3, Section for Hematology, Umeå

92121

Scripps Cancer Center, San Diego

91010-3000

City of Hope National Medical Center, Div. of Hematology & Bone Marrow Transplant, Duarte

94305-5821

Stanford University Medical Center, Division of Hematology, Stanford

06102

Hartford Hospital, Cancer Clinical Research Office, Hartford

02114

Massachusetts General Hospital, Boston

63110-1093

Washington University School of Medicine, Dept. of Internal Medicine/Division of Hematology, St Louis

T6G 2B7

University of Alberta, Cross Cancer Institute, Edmonton

04 75181

Hospital De L'Hotel Dieu, Hematologie et Oncologie Medicale, Cedex

10 75475

Hopital Saint-Louis, Centre G. Hayem-Secteur Bleu Porte 7, Laboratoire De Pathologie/Greffe de Moelle, Cedex

D-45147

Universitatsklinikum Essen, Zentrum fur Innere Medizin, Essen

D-17487

Universitatsklinik Greifswald, Innere Medizin C - Hamato-Onkologie, Greifswald

D-30625

Medizinische Hochschule Hannover, Abt. Hamatologie/Onkologie, Zentrum fur Innere Medizin, Hanover

D-66421

Saarland University Medical School, Internal Medicine 1, Homburg/Saar

D-89081

Institut fur Klinische Transfusionmedizin und Immungenetik, Abtlg. Transfusionsmedizin des Universitatskinikums Ulm, Ulm

I-16132

Ospedale San Martino, Dept. of Hematology, Genova

35-20122

Ospedale Maggiore di Milano, Divisione di Ematologia, Milan

5-80131

Universitar degli Studi di Napoli, Divisione di Ematologia, Azienda Universitar Policlinico, Napoli

37-36100

Ospedale San Bortolo, Divisione di Ematologia, Vicenza

SE-22185

Lund University Hospital, Department of Internal Medicine, Section of Hematology, Lund

TR1 3LJ

Royal Cornwall Hospital, Haematology Dept., Truro

BT9 7AB

Belfast City Hospital, Dept. of Haematology C Floor, Belfast

LS1 3EX

Leeds General Infirmary, D Floor Brotherton Wing, Leeds

SW17 OQT

St. George's Hospital, Department of Haematology, London

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY